Genedata Expressionist® enables biopharma to leverage the sensitivity and molecular insights provided by mass spectrometry for in-depth characterization and quality monitoring of RNA and oligonucleotide therapeutics.
Flexible. Automated. Compliance-Ready.
The structural complexity and multistep production processes of oligonucleotide-based drugs require advanced MS analytical methods for in-depth characterization and stringent quality monitoring.
Genedata Expressionist® provides a flexible platform for streamlining MS data processing, analysis, and reporting throughout the development of RNA-based therapeutics, from early discovery to downstream regulated environments.
"Genedata developed the end-to-end oligonucleotide QC data workflow and provided the consulting expertise throughout the entire project including the validation stage to help us achieve our goals on time and within budget."